Cargando…

Clinical Phenotypes of Progressive Supranuclear Palsy—The Differences in Interleukin Patterns

Progressive supranuclear palsy (PSP) is an atypical parkinsonian syndrome based on tau pathology; its clinical phenotype differs, but PSP with Richardson’s syndrome (PSP-RS) and the PSP parkinsonism predominant (PSP-P) variant remain the two most common manifestations. Neuroinflammation is involved...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madetko-Alster, Natalia, Otto-Ślusarczyk, Dagmara, Wiercińska-Drapało, Alicja, Koziorowski, Dariusz, Szlufik, Stanisław, Samborska-Ćwik, Joanna, Struga, Marta, Friedman, Andrzej, Alster, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606588/ https://www.ncbi.nlm.nih.gov/pubmed/37894815 http://dx.doi.org/10.3390/ijms242015135

Ejemplares similares

Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP)
por: Alster, Piotr, et al.
Publicado: (2020)

Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)
por: Alster, Piotr, et al.
Publicado: (2020)

The Use of Cerebellar Hypoperfusion Assessment in the Differential Diagnosis of Multiple System Atrophy with Parkinsonism and Progressive Supranuclear Palsy-Parkinsonism Predominant
por: Madetko-Alster, Natalia, et al.
Publicado: (2022)

The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)
por: Alster, Piotr, et al.
Publicado: (2022)

Accumulation of Tau Protein, Metabolism and Perfusion—Application and Efficacy of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) Imaging in the Examination of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS)
por: Alster, Piotr, et al.
Publicado: (2019)

Mechanisms of Neurodegeneration in Various Forms of Parkinsonism—Similarities and Differences
por: Koziorowski, Dariusz, et al.
Publicado: (2021)

Influence of Bilateral Subthalamic Nucleus Deep Brain Stimulation on the Lipid Profile in Patients With Parkinson's Disease
por: Samborska-Ćwik, Joanna, et al.
Publicado: (2020)

Thalamic and cerebellar hypoperfusion in single photon emission computed tomography may differentiate multiple system atrophy and progressive supranuclear palsy
por: Alster, Piotr, et al.
Publicado: (2019)

The Strengths and Obstacles in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) Using Magnetic Resonance Imaging (MRI) and Perfusion Single Photon Emission Computed Tomography (SPECT)
por: Alster, Piotr, et al.
Publicado: (2022)

The Role of the Evans Index and the Maximal Width of the Frontal Horns of the Lateral Ventricles in the Diagnostic Imaging of Progressive Supranuclear Palsy and Multiple-System Atrophy
por: Kutyłowski, Michał, et al.
Publicado: (2023)

The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study
por: Alster, Piotr, et al.
Publicado: (2021)

Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism
por: Krzosek, Patrycja, et al.
Publicado: (2022)

Inflammation in multiple system atrophy
por: Leńska-Mieciek, Marta, et al.
Publicado: (2023)

The Role of Frontal Assessment Battery and Frontal Lobe Single-Photon Emission Computed Tomography in the Differential Diagnosis of Progressive Supranuclear Palsy Variants and Corticobasal Syndrome—A Pilot Study
por: Alster, Piotr, et al.
Publicado: (2021)

Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives
por: Madetko, Natalia, et al.
Publicado: (2022)

Is MRPI 2.0 More Useful than MRPI and M/P Ratio in Differential Diagnosis of PSP-P with Other Atypical Parkinsonisms?
por: Madetko, Natalia, et al.
Publicado: (2022)

The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes
por: Alster, Piotr, et al.
Publicado: (2022)

Assessment of factors influencing glymphatic activity and implications for clinical medicine
por: Gędek, Adam, et al.
Publicado: (2023)

Proteomic Profile of Saliva in Parkinson’s Disease Patients: A Proof of Concept Study
por: Figura, Monika, et al.
Publicado: (2021)

Glymphatic System and Mitochondrial Dysfunction as Two Crucial Players in Pathophysiology of Neurodegenerative Disorders
por: Kopeć, Kamila, et al.
Publicado: (2023)

Making a Difference—Positive Effect of Unilateral VIM Gamma Knife Thalamotomy in the Therapy of Tremor in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
por: Alster, Piotr, et al.
Publicado: (2018)

Machine Learning and Eye Movements Give Insights into Neurodegenerative Disease Mechanisms
por: Przybyszewski, Andrzej W., et al.
Publicado: (2023)

Multimodal Learning and Intelligent Prediction of Symptom Development in Individual Parkinson’s Patients
por: Przybyszewski, Andrzej W., et al.
Publicado: (2016)

Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies
por: Jakimiuk, Alicja, et al.
Publicado: (2023)

The Neuromodulatory Impact of Subthalamic Nucleus Deep Brain Stimulation on Gait and Postural Instability in Parkinson's Disease Patients: A Prospective Case Controlled Study
por: Szlufik, Stanislaw, et al.
Publicado: (2018)

A Multimodal Approach to the Quantification of Kinetic Tremor in Parkinson’s Disease
por: Szumilas, Mateusz, et al.
Publicado: (2019)

Cervical dystonia and no oculomotor apraxia as new manifestation of ataxia-telangiectasia-like disorder 1 – case report and review of the literature
por: Bajek, Agnieszka, et al.
Publicado: (2023)

Impact of Combined Antiretroviral Therapy on Metabolic Syndrome Components in Adult People Living with HIV: A Literature Review
por: Sapuła, Mariusz, et al.
Publicado: (2022)

Serum amino acid profile in patients with Parkinson’s disease
por: Figura, Monika, et al.
Publicado: (2018)

Zolpidem in Progressive Supranuclear Palsy
por: Dash, Sandip K.
Publicado: (2013)

Genetics of Progressive Supranuclear Palsy
por: Im, Sun Young, et al.
Publicado: (2015)

Falls in Progressive Supranuclear Palsy
por: Brown, Fraser S., et al.
Publicado: (2019)

In Search of Risk Factors for Recurrent Erysipelas and Cellulitis of the Lower Limb: A Cross-Sectional Study of Epidemiological Characteristics of Patients Hospitalized due to Skin and Soft-Tissue Infections
por: Sapuła, Mariusz, et al.
Publicado: (2020)

Hepatopathy of unknown etiology – is liver biopsy a good tool in differential diagnosis?
por: Jabłońska, Joanna, et al.
Publicado: (2019)

Soluble Urokinase Plasminogen Activator Receptor Levels Correlation with Other Inflammatory Factors in Prognosis of Disability and Death in Patients with Ischemic Stroke
por: Różański, Dorota, et al.
Publicado: (2021)

Synthesis of Lasalocid-Based Bioconjugates and Evaluation of Their Anticancer Activity
por: Antoszczak, Michał, et al.
Publicado: (2022)

‘Hummingbird’ sign in progressive supranuclear palsy
por: Shukla, Rakesh, et al.
Publicado: (2009)

Clinical Approach to Progressive Supranuclear Palsy
por: Ling, Helen
Publicado: (2016)

Managing cognition in progressive supranuclear palsy
por: Rittman, Timothy, et al.
Publicado: (2016)

Hummingbird sign in progressive supranuclear palsy
por: Verma, Rajesh, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ejpt91c9op3d7ml6ntjcu7rr0i